Picture of Biosynex SA logo

ALBIO Biosynex SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Brief: Biosynex Upgrades Its 2020 Turnover Target

Dec 1 (Reuters) - BIOSYNEX SA  ALBIO.PA :
    * UPGRADES ITS OBJECTIVE IN 2020 TURNOVER WITH A RANGE
BETWEEN €
150 MILLION AND € 170 MILLION
    * PLANS TO LAUNCH ITS CE CERTIFIED COVID-19 SEROLOGICAL
SELF-TEST
IN PHARMACIES IN SPAIN, ITALY AND BELGIUM FROM DECEMBER 2020


Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biosynex SA

See all news